Polarityte Analysis

PTEDelisted Stock  USD 0.07  0.01  10.29%   
Polarityte is overvalued with Real Value of 0.0712 and Hype Value of 0.08. The main objective of Polarityte delisted stock analysis is to determine its intrinsic value, which is an estimate of what Polarityte is worth, separate from its market price. There are two main types of Polarityte's stock analysis: fundamental analysis and technical analysis.
The Polarityte stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Polarityte's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Polarityte Stock Analysis Notes

The company has price-to-book ratio of 0.29. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Polarityte recorded a loss per share of 0.58. The entity last dividend was issued on the 12th of January 2016. The firm had 1:25 split on the 17th of May 2022. PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin and other tissue regeneration products. Polarityte operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. To find out more about Polarityte contact Richard Hague at 800 560 3983 or learn more at https://www.polarityte.com.

Polarityte Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Polarityte's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Polarityte or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Polarityte is not yet fully synchronised with the market data
Polarityte has some characteristics of a very speculative penny stock
Polarityte has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 814 K. Reported Net Loss for the year was (7.83 M) with profit before taxes, overhead, and interest of 198 K.
Polarityte has about 20.88 M in cash with (22.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Polarityte Upcoming and Recent Events

19th of June 2023
Upcoming Quarterly Report
View
10th of August 2023
Next Financial Report
View
31st of March 2023
Next Fiscal Quarter End
View
25th of March 2024
Next Fiscal Year End
View
31st of December 2022
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Polarityte Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 1.78 M.

Polarityte Outstanding Bonds

Polarityte issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Polarityte uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Polarityte bonds can be classified according to their maturity, which is the date when Polarityte has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Polarityte Predictive Daily Indicators

Polarityte intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Polarityte stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Polarityte Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Polarityte prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Polarityte shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Polarityte. By using and applying Polarityte Stock analysis, traders can create a robust methodology for identifying Polarityte entry and exit points for their positions.
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin and other tissue regeneration products. Polarityte operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Polarityte to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Polarityte Stock

If you are still planning to invest in Polarityte check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polarityte's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges